Clinical Trial Update: Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting efficacy and safety results for BMS-298585 alone and in combination with pravastatin in subjects with mixed dyslipidemia (Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• BMS-298585
• Pravastatin (pravastatin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Dyslipidemia | Phase 2, Phase 3 | Status: COMPLETED